Word

SEQUADERMA

Status

Dead

Status Code

709

Status Date

Friday, February 3, 2023

Serial Number

79171753

Registration Number

5000628

Registration Date

Tuesday, July 19, 2016

Mark Type

4000

Filing Date

Monday, April 20, 2015

Published for Opposition

Tuesday, May 3, 2016

Cancellation Date

Friday, February 3, 2023

Trademark Owner History

Pro Bono Bio Entrepreneur Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; veterinary preparations for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; sanitary preparations for medical use; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; topical and parenteral preparations of vesicles in the nature of pharmaceutical or medical preparations for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; chemical preparations in the form of vesicles for medical and veterinary purposes for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; chemical membranes and chemical aggregates for medical and veterinary purposes for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; preparations of arachidonic acids for medical or pharmaceutical purposes; dispersions and dry preparations of liposomal active substances for use as a pharmaceutical, cosmetic and veterinary substance carrier; cosmeceutical preparations for medical use for the treatment of pain and inflammation and diseases and disorders of the skin, eczema, psoriasis, acne, aging and thinning skin, rosacea and dermatitis; local anesthetics; lipids for topical and parenteral use for medical or pharmaceutical purposes; medical or pharmaceutical creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers, foams and film forming solution for the treatment of ocular conditions, subcutaneous conditions such as cellulitis, dermal conditions associated with all layers of the skin, superficial and deep; medical or pharmaceutical surfactants for use in the treatment of diseases affecting the immune system, inflammatory diseases, diseases of the skin, hair and ear, the treatment of pain and inflammation, rosacea and skin redness, atopic eczema, dishydrotic hand eczema, seborrhoeic eczema, pruritus and other skin irritations, plaque type psoriasis, acne vulgaris, breakouts, spots and other blemishes, bacterial, fungal and viral infections related to the skin and/or its secretions, male pattern baldness, the treatment of wrinkles, eye-bags, pigmentation disorders and other dermatological conditions caused by skin aging and other forms of damage or where skin supporting structures become weakened

3 Non-medicated toiletries, non-medicated skin care preparations, face cleansers, non-medicated cosmetic preparations for skin care, beauty serums; beauty balms; non-medicated skin balms, skin toners, non-medicated exfoliating preparations for skin; gel eye masks, facial beauty masks; non-medicated skin creams, oils, lotions and sprays; non-medicated skin conditioners, skin moisturisers, eye cream, eye gel, lip moisturisers, lip balm, hand cream, body lotions, body wash, foot balms, body scrubs; essential oils, fragrances, soap, hair care preparations, dentifrices

10 Medical devices for topical use in the treatment of dermal conditions associated with all layers of the skin, superficial and deep, namely, medical devices in the nature of a carrier with nanostructures which cross through the skin, allowing subcutaneous adsorption for the treatment of conditions of the skin; molecular filtering devices for medical purposes, namely, a gel or cream preparation as a drug delivery device which filters through or migrates into the skin and has a physical therapeutic effect; medical, veterinary and surgical apparatus, instruments and devices, namely, a medical device in which vesicles act as a drug delivery device in the nature of non-pharmaceutical nanostructures that migrate through the skin and have a physical therapeutic effect; inhalers for medical purposes sold empty; injection apparatus, instruments and devices, namely, injection needles, injection instruments without needles; medical and surgical apparatus, instruments and devices for the administration of skin disease and aging therapy and prophylaxis preparations and substances

Trademark Events

Oct 31, 2023

Total Invalidation Processed By The Ib

Oct 7, 2023

Total Invalidation Of Reg Ext Protection Sent To Ib

Oct 7, 2023

Invalidation Processed

Oct 3, 2023

Total Invalidation Of Reg Ext Protection Created

Feb 3, 2023

Cancelled Section 71

Jul 19, 2021

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Jan 3, 2020

New Representative At Ib Received

Aug 9, 2019

New Representative At Ib Received

Dec 23, 2016

Final Decision Transaction Processed By Ib

Dec 6, 2016

Final Disposition Notice Sent To Ib

Dec 6, 2016

Final Disposition Processed

Oct 19, 2016

Final Disposition Notice Created, To Be Sent To Ib

Jul 28, 2016

Notification Of Possible Opposition - Processed By Ib

Jul 19, 2016

Registered-Principal Register

May 3, 2016

Official Gazette Publication Confirmation E-Mailed

May 3, 2016

Published For Opposition

Apr 20, 2016

Notification Of Possible Opposition Sent To Ib

Apr 20, 2016

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 13, 2016

Notification Of Notice Of Publication E-Mailed

Mar 31, 2016

Approved For Pub - Principal Register

Mar 15, 2016

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 15, 2016

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 15, 2016

Teas/Email Correspondence Entered

Mar 15, 2016

Correspondence Received In Law Office

Mar 15, 2016

Teas Response To Office Action Received

Oct 2, 2015

Refusal Processed By Ib

Sep 16, 2015

Non-Final Action Mailed - Refusal Sent To Ib

Sep 16, 2015

Refusal Processed By Mpu

Sep 16, 2015

Non-Final Action (Ib Refusal) Prepared For Review

Sep 15, 2015

Non-Final Action Written

Sep 12, 2015

Application Filing Receipt Mailed

Sep 8, 2015

Assigned To Examiner

Sep 8, 2015

Assigned To Examiner

Sep 8, 2015

New Application Office Supplied Data Entered

Sep 3, 2015

Sn Assigned For Sect 66a Appl From Ib